Bristol Myers Squibb GmbH & Co. KGaA
About
Bristol Myers Squibb ist ein weltweit tätiges Biopharma-Unternehmen mit einer klaren Mission: Die Erforschung, Entwicklung und Bereitstellung von innovativen Medikamenten, die Patient:innen dabei helfen, schwere Erkrankungen zu überwinden.
Address
Arnulfstr. 29
80636 München
Contact details
Medical Information phone number
+49-(0)800-0752002
Hours of operation
Mo. - Fr. 9:00 - 17:00
Medical Information website
https://www.bmsmedinfo.de/
Medical Information email
medwiss.info@bms.com
Click to chat
https://www.bmsmedinfo.de/
Adverse events and product complaints
Please use the contact details below to provide adverse events or product complaints
Adverse event phone number
+49-(0)800-0752002
Adverse event email
medwiss.info@bms.com
Submit medical inquiry
https://www.bmsmedinfo.de/emirf_de
Company website
https://www.bms.com/de
BMS products
Medicinal products marked with▼are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Abecma ▼
(idecabtagene vicleucel)
ABRAXANE®
(nab-paclitaxel)
BARACLUDE®
(entecavir)
Breyanzi ▼
(lisocabtagen maraleucel)
CAMZYOS ▼
(mavacamten)
ELIQUIS® (Co-Promoted Pfizer)
(apixiban)
EMPLICITI®
(elotuzumab)
IMNOVID® ▼
(pomalidomide)
INREBIC® ▼
(fedratinib)
NULOJIX®
(belatacept)
ONUREG®
(azacitidine tablets)
OPDIVO®
(nivolumab)
OPDIVO® + YERVOY® Regimen
(nivolumab, ipilimumab)
ORENCIA®
(abatacept)
REBLOZYL® ▼
(luspatercept)
REVLIMID® ▼
(lenalidomide)
REYATAZ®
(atazanavir)
SOTYKTU ▼
(deucravacitinib)
SPRYCEL®
(dasatinib)
Thalidomide BMS®
(thalidomide)
VIDAZA®
(azacitidine)
YERVOY®
(ipilimumab)
ZEPOSIA® ▼
(ozanimod)
